stockportfolio.pro
Stocks / ARWR vs MOH
ARWR vs MOH
Arrowhead Pharmaceuticals, Inc. and Molina Healthcare, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Arrowhead Pharmaceuticals, Inc. (ARWR) | Molina Healthcare, Inc. (MOH) | |
|---|---|---|
| Market cap | $10.0B | $10.3B |
| Revenue (latest FY) | $829.45M | $45.43B |
| Net income (latest FY) | $-1.63M | $472.00M |
| Revenue growth (5y CAGR) | 56.6% | 18.5% |
| Net margin | -0.2% | 1.0% |
| Return on equity | -0.3% | 11.6% |
| P/E ratio | — | 52.7 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 1 | 9 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ARWR — free Open MOH — freeFrequently asked questions
Which is bigger, ARWR or MOH?
Molina Healthcare, Inc. is larger by market capitalization — $10.3B versus $10.0B.
Which grows faster, ARWR or MOH?
Over the last five fiscal years, Arrowhead Pharmaceuticals, Inc. grew revenue faster — 56.6%/yr versus 18.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.